Driving Therapeutic Innovation Forward
Therapeutic Labs @ TMC is a purpose-built environment that gives startups and growth-stage innovators the infrastructure and community needed to fast-track therapeutic research and development. The Labs feature fully equipped biology and chemistry labs, shared instrumentation, and advanced technologies, all designed to support every stage of your journey.
It’s a connected ecosystem, surrounded by world-class institutions, clinical collaborators, and mentors, with the tools and support you need on-site every day.
Space Designed for Discovery
Office Space & Amenities
- Private 2-desk to 6-desk offices
- Single-desk workstations in shared space
- Conference Rooms
- 24/7 secure Building Access
- Online portal to reserve equipment, rooms, or request support
- Business Center with Printers
- Mailroom Services
- Access to Atrium
- Shared Kitchen and Break Area
Lab Space & Amenities
- Single-bench shared lab for early-stage development
- Private BSL1 labs and BSL2 cell culture labs
- N2, CO2, Vacuum, and Compressed Air
- Shared BSL2 Cell Culture, Bacteria, and Virology Labs with Biosafety Cabinets, Centrifuges, Microscopes, and Incubators
- Monitored Cold Storage with Redundant Power Supplies
- Milli-Q Water, Glass Wash, Autoclave, Dry Ice, and Liquid Nitrogen
- Access to Common and Speciality Equipment
The Community
At Therapeutic Labs @ TMC, the real strength lies in the people shaping the future of medicine within its walls. Beyond fully equipped lab spaces and advanced instrumentation, it’s the community of innovators, researchers, mentors, Entrepreneurs in Residence, and growth-stage companies that makes this space exceptional.
Shape the Future of Therapeutics
Companies at Therapeutic Labs @ TMC
7 Hills Pharma is advancing first-in-class integrin-targeted agonists designed to safely improve the effectiveness of immuotherapies for cancer and stem cell transplantation.
Asclepia Technology is a company developing targeted vascular stem cell therapies using innovative delivery technologies to repair arteries and treat atherosclerotic vascular disease.
Autology focuses on the science and development of products from living systems, exploring biotechnology and biological automation.
Case45, a digital oncology company leveraging artificial intelligence to advance the discovery of cancer biomarkers and therapies.
CorInnova is developing a minimally invasive, non-blood-contacting cardiac assist device for the treatment of acute heart failure.
Elate Medical’s mission is to discover next-generation antibodies and develop innovative cellular products that are safer, more effective, and widely accessible.
EXoPERT is a biotech company developing novel liquid biopsy technology to enable early cancer detection and improve patient outcomes through ongoing research and innovation.
G9 Bio is a patented leader in pharmaceutical delivery, developing innovative Microneedle Array Patch (MAP) platform technologies for next-generation therapeutics and vaccines.
GlycosBio uses enzymology and advanced lipid engineering to develop a library of Activated Oil Systems that unlock novel therapeutic benefits to patients.
Heliowave provides advanced contamination-free solutions across industries, including pharmaceuticals and food safety, ensuring optimal performance, efficiency, and consumer trust.
ImmunoGenesis is a clinical-stage immuno-oncology company developing therapies to overcome immune-excluded “cold” tumors, driving effective immune responses where current immunotherapies fail.
InstaPath develops rapid, slide-free digital pathology platforms that enable faster, more accurate cancer diagnoses, improving patient care and reducing delays in treatment.
LabReady develops AI-enabled, lab-grade multiplex qPCR diagnostics that bring fast, accurate infection testing directly to farmers, healthcare providers, and businesses—outside traditional labs.
Lindonlight transforms bold scientific ideas into real-world solutions — improving outcomes and accelerating hope for children with brain tumors.
Medley Therapeutics, formerly known as YAP Therapeutics, develops advanced biologics and gene therapies, including YAP101, to regenerate organs, treat cardiac arrhythmias, and address chronic and life-threatening diseases.
Path EX is pioneering sepsis treatment with its CycloPE® device, which directly captures and removes bacteria from the bloodstream, offering a rapid, targeted approach to improve patient survival.
Pendant Biosciences develops a polymer-based drug-delivery platform, offering next-generation technology.
Resonant Therapeutics’ platform generates antibodies against targets other technologies have missed, cutting years off the discovery process.
Starling Medical equips users with the tools and real-time insights needed to maintain healthy habits and access to care options.
TMAB Therapeutics’ mission is to develop the world’s best and first-in-class radiopharmaceuticals designed to combat treatment-resistant cancers.
TYBR Health is committed to developing cutting-edge biomaterial therapies that simplify recovery, reduce complications, and enhance patient outcomes.
Velvet Therapeutics, an early-stage biotech company, focuses on developing novel chimeric antigen receptors using a non-viral, DNA delivery platform.
Wellysis aims to improve ECG testing accessibility, reduce individual inconveniences, and streamline the testing process, enabling individuals to monitor their heart health in everyday life.
Waventra Therapeutics is a biotechnology company aiming to preserve tissue by protecting the microvasculature and cellular survival pathways during ischemia-reperfusion injury.